年度报告 ANNUALREPORT 創美藥業股份有限公司（股份代號：2289.HK）主營醫藥分銷業務，主要向下游分銷商和零售終端分銷西藥、中成藥、保健品等產品，並提供醫藥產品諮詢服務。公司創立於2000年，經過22年的快速發展，已成長為華南地區領先的醫藥分銷商之一。公司堅持「深耕廣東，輻射周邊」的發展戰略，在汕頭、佛山、珠海、廣州及惠州設有物流中心並擁有專業的運輸服務團隊，對非招標市場實行「半徑10公里內一日三配、50公里內一日兩配、250公里內一日一配」的高效配送機制。公司具有現代化信息系統，涵蓋整個醫藥分銷供應鏈，包括採購、銷售、倉儲、運輸及交付等。公司同時運營自建的B2B電子商務平臺：「創美e藥」，供客戶線上 下單、查 詢及支付 等。 公司於2020年全國批發企業主營業務收入前100位排序前40。根據標點資訊《 中 國 醫 藥 行 業 市 場 研 究 報 告 》(2017)，公司的銷售規模在廣東省醫藥分銷企業中排名第7，在民營企業中排名第2。 憑 籍良好的 信譽和優 質服 務，於2021年1月，本公司獲得由全國工Charmacy Pharmaceutical Co., Ltd. (stock code: 2289.HK) is principally engaged in the pharmaceutical distribution business. It mainly distributes western medicine, Chinese patent medicine and healthcare products to downstream distributors and retail terminals, as well as provides consultation service on pharmaceutical products. Founded in 2000, over the past 22 years of rapid development, it has become one of the leading pharmaceutical distributors in the Southern China region. The Company adheres to the development strategy of ―Intensive Engagement in Guangdong Province and Extensive Coverage across Surrounding Areas‖, and has built logistics centres in Shantou, Foshan, Zhuhai, Guangzhou and Huizhou, all equipped with professional transportation teams, and has a highly efficient delivery mechanism of delivering pharmaceutical products three times per day for customers within a radius of 10 kilometers, twice per day for customers within a radius of 50 kilometers and once per day for those within a radius of 250 kilometers. In addition, the Company has a modern information system that covers the entire supply chain for pharmaceutical distribution, including procurement, sales, warehousing, transportation and delivery. Apart from that, the Company operates its own B2B e-commerce platform ―Charmacy e-Medicine‖ (創美e藥), a platform for customers to place orders online, make inquires and payment ,etc. In 2020, the Company ranked top 40 among top 100 PRC wholesalers, in respect of revenue generated from the principal business. According to the Market Research Report of the Chinese Pharmaceutical Industry (2017) (《中國醫藥行業市場研究報告》(2017)), in respect of sales scale, the Company ranked the 7th among the pharmaceutical distribution businesses in Guangdong Province and the 2nd among private enterprises. With the good reputation and high-quality service, in January 2021, the Group it was awarded the 2020 Most Promising 商聯醫藥業商會醫藥商業分會頒發的2020年度醫藥商業最具發展潜力企業。於2021年3月，獲得由醫藥供應鏈聯盟、藥鏈圈共同頒發的2020-2021年度醫藥冷鏈物流最佳物流中心（基地），及2020-2021年度醫藥冷鏈物流服務推薦企業。於2021年6月，獲得由中國（廣州）國際物流裝備與技術展組委會頒發的2020-2021年度中國物流行業金螞蟻創新獎及獲得由廣東省市場監督管理局頒發 的 廣 東 省 守 合 同 重 信 用 企 業（2001-2020連續二十年）。於2021年7月，獲得由藥鏈圈頒發的2021年 度醫藥物 流配送優 秀企 業。於2021年9月，獲得由中華全國工商業聯合會醫藥業商會頒發的2020年度中國醫藥行業醫藥商業百強企業。於2021年10月，獲得由汕頭市藥業商 會頒發的 抗疫積極 貢獻 獎。於2021年12月，獲得由中國物流與采購聯合會醫藥物流分會頒發的2020-2021年度醫藥供應鏈‖金質獎‖——十佳商業企業。獲得由中國企業聯合會、中國企業家協會頒發的企業信用評價AAA級信用企業。獲得由全國物流標準化技術委員會冷鏈物流分技術委員會、中國物流與采購聯合會醫藥物流分會頒發的《藥品冷鏈物流運作規範》國家標準達標企業。 Enterprise in The Pharmaceutical Business industry by the Pharmaceutical Business Branch of the All-China Federation of Industry and Commerce. In March 2021, it was appraised as the Best Logistics Center for Pharmaceutical Cold Chain Logistics (Base) in 2020-2021 and the Medical cold chain logistics services recommended enterprises in 2020-2021 by the Pharmaceutical Supply Chain Alliance and Yao lian quan. In June 2021, it was awarded the ―Golden Ant‖ Innovation Award of Chinese Logistics Industry from 2020 to 2021 issued by China (Guangzhou) International Logistics Equipment and Technology Exhibition Organising Committee and the title of Contract Abiding and Credit Respecting Enterprise in Guangdong Province (for 20 consecutive years from 2001 to 2020) by Guangdong Provincial Market Supervision Administration. In July 2021, it was awarded the 2021 Annual Pharmaceutical Logistics and Distribution Outstanding Enterprise by the Yao Lian Quan. In September 2021, it was awarded the 2020 Top 100 Pharmaceutical Enterprises in China’s Pharmaceutical Industry issued by the China National Federation of Industry and Commerce Pharmaceutical Industry And Commerce Association. In October 2021, it won the Anti-epidemic Positive Contribution Award issued by the Shantou Pharmaceutical Industry Association. In December 2021, it won the ―Gold Award‖ for the 2020-2021 Medical Supply Chain-- Procurement - Top Ten Commercial Enterprises issued by the Pharmaceutical Logistics Branch of the China Federation of Logistics. it was awarded the AAA credit rating issued by the China Enterprise Confederation and the China Entrepreneurs Association. It has obtained the national standard of ―Pharmaceutical Cold Chain Logistics Operation Specification‖ issued by the National Logistics Standardisation Technical Committee Cold Chain Logistic